Related Experiment Video

Updated: Jun 17, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.8K

Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and

Smruthy Sivakumar1, Jay A Moore1, Meagan Montesion1

  • 1Foundation Medicine, Inc., Cambridge, Massachusetts.

Cancer Discovery
|April 16, 2023
PubMed

Insights

This study analyzed 3,600 small cell lung cancer (SCLC) cases, identifying new genetic subtypes and alterations. These findings offer potential for personalized treatment strategies for SCLC patients.

Area of Science:

  • Oncology
  • Genetics
  • Cancer Research

Background:

  • Small cell lung cancer (SCLC) is an aggressive neuroendocrine cancer with poor survival rates.
  • Limited human tumor data has hindered progress in SCLC research and treatment development.

Purpose of the Study:

  • To conduct an integrated analysis of a large cohort of "real-world" SCLC cases.
  • To identify novel genetic alterations, subtypes, and potential therapeutic targets in SCLC.
  • To explore the molecular mechanisms of SCLC transformation from non-small cell lung cancer (NSCLC).

Main Methods:

  • Integrated analysis of 3,600 real-world SCLC patient cases.
  • Genomic profiling to identify recurrent alterations and genetic subtypes.
  • Comparative analysis of SCLC with oncogenic drivers typically found in NSCLC.

Main Results:

  • Identification of STK11-mutant (1.7%) and TP53/RB1 wild-type (5.5%) SCLC subtypes, and rare human papillomavirus-positive cases.
  • 4q12 gene amplifications correlated with improved overall survival; CCNE1 amplification associated with decreased survival.
  • Frequent PTEN pathway alterations observed in brain metastases; SCLC transformation linked to diverse NSCLC molecular subtypes.

Conclusions:

  • Novel genetic features of SCLC have been uncovered, including distinct subtypes and pathway alterations.
  • Findings suggest SCLC can arise from multiple molecular subtypes of NSCLC.
  • These discoveries may pave the way for personalized treatment strategies for SCLC.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...